MSc (University of Toronto), PhD (University of Toronto)
Teaching and research interests: in vivo models of human disease. Particularly, using the mice as an in vivo model to study the molecular mechanism of action of new therapies for the treatment of diabetes and associated metabolic disorders. In addition, using mice models to understand the molecular mechanism of action of insulinotropic ligands and their Gpcrs.
Diabetes Cancer Insulin intolerance Microbiota and its interaction with the gut GPCRs (GPR40, 41/42, GPR119, GLP1r) Inflammation